Interventional Cardiology

An occlusion-first strategy in atrial fibrillation treatment shows superior long-term outcomes, reducing complications and improving arrhythmia control.

The CLEAR-IE study highlights the clinical effectiveness of percutaneous mechanical aspiration in treating right-sided infective endocarditis resistant to medical therapy.

A recent study has revealed that sirolimus-coated balloons are comparable to paclitaxel-coated balloons for treating femoropopliteal artery disease.

The ACCESS-TAVI trial demonstrated that a combined suture/plug-based vascular closure device strategy significantly reduces vascular complications and bleeding events.

The PEERLESS trial demonstrated that large-bore mechanical thrombectomy was more effective than catheter-directed thrombolysis for pulmonary embolism

Patients under 65 years undergoing TAVR exhibit a higher comorbidity burden and greater all-cause mortality

Early transcatheter aortic-valve replacement is more effective than clinical surveillance in reducing adverse outcomes in patients with asymptomatic severe aortic stenosis.

The SCAI has presented detailed guidance to help interventional cardiologists optimise primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction.